Lincoln Capital LLC Has $17.39 Million Stake in Danaher Corporation $DHR

Posted by on Aug 6th, 2026

Lincoln Capital LLC increased its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 7.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 91,284 shares of the conglomerate’s stock after buying an additional 6,558 shares during the quarter. Danaher accounts for 3.1% of Lincoln Capital LLC’s portfolio, making the stock its 7th biggest holding. Lincoln Capital LLC’s holdings in Danaher were worth $17,388,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in DHR. Northwestern Mutual Wealth Management Co. lifted its position in Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the period. SeaBridge Investment Advisors LLC acquired a new position in shares of Danaher in the 4th quarter valued at $4,477,000. Legal & General Group Plc raised its stake in shares of Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after buying an additional 43,169 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Danaher by 220.2% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 674,373 shares of the conglomerate’s stock worth $154,377,000 after acquiring an additional 463,764 shares during the period. Finally, Whittier Trust Co. boosted its position in shares of Danaher by 12.2% during the 4th quarter. Whittier Trust Co. now owns 292,894 shares of the conglomerate’s stock valued at $69,296,000 after acquiring an additional 31,790 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $199.52 on Thursday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a 50 day moving average of $189.84 and a 200-day moving average of $194.50. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a market cap of $140.26 billion, a price-to-earnings ratio of 35.44, a PEG ratio of 2.43 and a beta of 0.78.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.77 EPS. On average, equities analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on DHR shares. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. The Goldman Sachs Group lowered their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Finally, Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Read Our Latest Stock Analysis on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.